{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:22:11Z","timestamp":1762867331490},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Huazhong Univ. Sci. Technol. [Med. Sci.]"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s11596-017-1696-x","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T22:02:13Z","timestamp":1515448933000},"page":"70-73","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome"],"prefix":"10.1007","volume":"37","author":[{"given":"Fan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Rong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,22]]},"reference":[{"key":"1696_CR1","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.fertnstert.2006.03.012","volume":"86","author":"E Carmina","year":"2006","unstructured":"Carmina E, Azziz R. Diagnosis, phenotype, and prevalence of polycystic ovary syndrome. Fertil Steril, 2006,86(Supp 1):S7\u2013S8","journal-title":"Fertil Steril"},{"issue":"2","key":"1696_CR2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1530\/rep.1.01075","volume":"132","author":"C Itman","year":"2006","unstructured":"Itman C, Mendis S, Barakat B, et al. All in the family: TGF-beta family action in testis development. Reproduction, 2006,132(2): 233\u2013246","journal-title":"Reproduction"},{"issue":"1","key":"1696_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/rep.1.00529","volume":"131","author":"JA Visser","year":"2006","unstructured":"Visser JA, de Jong FH, Laven JS, et al. Anti-mullerian hormone: a new marker for ovarian function. Reproduction, 2006,131(1): 1\u20139","journal-title":"Reproduction"},{"issue":"1","key":"1696_CR4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.fertnstert.2010.04.006","volume":"95","author":"KR Hansen","year":"2011","unstructured":"Hansen KR, Hodnett GM, Knowlton N, et al. Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil Steril, 2011, 95(1): 170\u2013175","journal-title":"Fertil Steril"},{"issue":"5","key":"1696_CR5","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0002-9378(96)70032-7","volume":"175","author":"J Balasch","year":"1996","unstructured":"Balasch J, Creus M, Fabregues F, et al. Inhibin, follicle-stimulating hormone, and age as predictors of ovarian response in vitro fertilization cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment. Am J Obstet Gynecol, 1996,175(5): 1226\u20131230","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"1696_CR6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/gye.17.4.287.293","volume":"17","author":"C Ficicioglu","year":"2003","unstructured":"Ficicioglu C, Kutlu T, Demirbasoglu S, et al. The role of inhibin B as a basal determinant of ovarian reserve. Gynecol Endocrinol, 2003,17(4): 287\u2013293","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"1696_CR7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0015-0282(97)81865-1","volume":"67","author":"DB Seifer","year":"1997","unstructured":"Seifer DB, Lambert Messerlian G, Hogan JW, et al. Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertil Steril, 1997,67(1): 110\u2013114","journal-title":"Fertil Steril"},{"issue":"2","key":"1696_CR8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/jc.2006-1582","volume":"92","author":"L Pellatt","year":"2007","unstructured":"Pellatt L, Hanna L, Bfineat M, et al. Granulosa cell production of anti-mullerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab, 2007,92(2): 240\u2013245","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1696_CR9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/humupd\/dmq034","volume":"17","author":"SL Broer","year":"2011","unstructured":"Broer SL, Dolleman M, Opmeer BC, et al. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Hum Reprod Update, 2011,17(1): 46\u201354","journal-title":"Hum Reprod Update"},{"issue":"2","key":"1696_CR10","first-page":"e44","volume":"28","author":"W Sarah","year":"2015","unstructured":"Sarah W, Maya L, Evgenia G, et al. AMH levels in adolescents with polycystic ovary syndrome (PCOS). J Pediatr Adolesc Gynecol, 2015,28(2):e44\u2013e45","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"2","key":"1696_CR11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejogrb.2012.04.014","volume":"163","author":"V Christos","year":"2012","unstructured":"Christos V, Neoklis AG, Anastasia KA, et al. Sibutramine administration decreases serum anti-Mullerian hormone (AMH) levels in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol, 2012,163(2): 185\u2013189","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"1696_CR12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/molehr\/gah015","volume":"20","author":"C Weenen","year":"2014","unstructured":"Weenen C, Laven JS, Von Bergh AR, et al. Anti-mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod, 2014,20(2): 77\u201383","journal-title":"Mol Hum Reprod"},{"issue":"3","key":"1696_CR13","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1210\/endo.143.3.8691","volume":"143","author":"AL Durlinger","year":"2002","unstructured":"Durlinger AL, Gruijters MJ, Kramer P, et al. Anti-mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology, 2002, 143(3): 1076\u20131084","journal-title":"Endocrinology"},{"issue":"2","key":"1696_CR14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","volume":"16","author":"A Marca La","year":"2010","unstructured":"La Marca A, Sighinolfi G, Radi D, et al. Anti-mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Human Reprod Update, 2010,16(2): 113\u2013130","journal-title":"Human Reprod Update"},{"issue":"5","key":"1696_CR15","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.fertnstert.2004.03.061","volume":"82","author":"A Hazout","year":"2004","unstructured":"Hazout A, Bouchard P, Seifer DB, et al. Serum anti-mullerian hormone\/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertil Steril, 2004,82(5): 1323\u20131329","journal-title":"Fertil Steril"},{"issue":"4","key":"1696_CR16","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.maturitas.2009.06.007","volume":"63","author":"CB Lambalk","year":"2009","unstructured":"Lambalk CB, Van Disseldorp J, de Koning CH, et al. Testing ovarian reserve to predict age at menopause. Maturitas, 2009,63(4): 280\u2013291","journal-title":"Maturitas"},{"issue":"1-2","key":"1696_CR17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mce.2004.09.008","volume":"234","author":"JA Visser","year":"2005","unstructured":"Visser JA, Themmen AP. Anti-mullerian hormone and folliculogenesis. Mol Cell Endocrinol, 2005,234(1-2): 81\u201386","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"1696_CR18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/humrep\/det413","volume":"29","author":"CA Clark","year":"2014","unstructured":"Clark CA, Laskin CA, Cadesky K. Anti-mullerian hormone: reality check. Human Reprod, 2014,29(1): 184\u2013185","journal-title":"Human Reprod"},{"issue":"1","key":"1696_CR19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/humupd\/dms041","volume":"19","author":"SL Broer","year":"2013","unstructured":"Broer SL, van Disseldorp J, Broeze KA, et al. Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data appmach. Hum Reprod Update, 2013,19(1): 26\u201336","journal-title":"Hum Reprod Update"},{"issue":"1","key":"1696_CR20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.fertnstert.2013.09.037","volume":"101","author":"RF Shayya","year":"2014","unstructured":"Shayya RF, Rosencrantz MA, Chuan SS, et al. Decreased inhibin B responses following recombinant human chorionic gonadotropin administration in normal women and women with polycystic ovary syndrome. Fertil Steril, 2014,101(1): 275\u2013279","journal-title":"Fertil Steril"},{"issue":"1","key":"1696_CR21","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/humrep\/17.6.1535","volume":"17","author":"M Fawzy","year":"2002","unstructured":"Fawzy M, Lambert A, Harrison RF, et al. Day 5 inhibin B levels in a treatment cycles are predictive of IVF outcome. Hum Reprod, 2002,17(1): 1535\u20131543","journal-title":"Hum Reprod"},{"issue":"3","key":"1696_CR22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/humupd\/dmh057","volume":"11","author":"S Luisi","year":"2005","unstructured":"Luisi S, Florio P, Reis FM, et al. Inhibins in female and male reproductive physiology: role in gametogenesis, conception, implantation and early pregnancy. Hum Reprod Update, 2005,11(3): 123\u2013135","journal-title":"Hum Reprod Update"},{"issue":"2","key":"1696_CR23","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.gyobfe.2006.09.012","volume":"34","author":"A Hazout","year":"2006","unstructured":"Hazout A. Quality of ovarian reserve: inhibin B on day 3 of the cycle or antimullerian hormone (AMH). Gynecol Obstet Fertil, 2006,34(2): 1001\u20131002","journal-title":"Gynecol Obstet Fertil"}],"container-title":["Journal of Huazhong University of Science and Technology [Medical Sciences]"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-017-1696-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11596-017-1696-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-017-1696-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T04:09:48Z","timestamp":1570594188000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11596-017-1696-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["1696"],"URL":"https:\/\/doi.org\/10.1007\/s11596-017-1696-x","relation":{},"ISSN":["1672-0733"],"issn-type":[{"value":"1672-0733","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}